RCC prospects Genitourinary March 21, 2023 Top Line: SABR is likely underutilized in the treatment of early stage, inoperable renal cell carcinoma due to limited prospective…
Genomic’s Eleven Genitourinary November 21, 2022 Top Line: Bladder preserving therapy for muscle-invasive bladder cancer (MIBC) is a category 1 strategy per NCCN, but we all…
Light combo Genitourinary October 17, 2022 Stage IIA and IIB seminoma includes N1-2 disease, and they are typically treated with either radiation or 3-4 cycles of…
Natural selection Genitourinary May 26, 2022 Of statistical analyses. This interesting study demonstrates that use of a novel stats trick for retrospective studies borrowed from the…
BC2022 Genitourinary May 24, 2022 Top Line: What are the long-term outcomes after bladder preservation therapy for muscle invasive bladder cancer? The Study: BC2001 was…
